A recent study confirmed that deacetylation-dependent nuclear translocation of PD-L1 promotes immune escape and upregulates the immune checkpoint genes such as PD-L2 and VISTA of tumor cells, thereby mediating resistance to PD-1/PD-L1 inhibitors[34]. The gene discussed is CD274; the disease is neoplasm.